RyanJZwerlingCPravEJ. Occupational risks associated with cigarette smoking: A prospective study. Am J Public Health. 1992;82:29–32.
2.
RyanJZwerlingCJonesM. Cigarette smoking at hire as a predictor of employment outcome. J Occup Environ Med. 1996;38:928–933.
3.
HalpernMTKhanZMYoungTLBattistaC. Economic model of sustained-release bupropion hydrochloride in health plan and worksite smoking cessation programs. Am J Health Syst Pharm. 2000;57:1421–1429.
4.
JavitzHSZbikowskiSMSwanGEJackLM. Financial burden of tobacco use: An employer's perspective. Clin Occup Environ Med. 2006;5:9–29.
5.
FioreMCBaileyWCCohenSJ. Treating Tobacco Use and Dependence, Clinical Practice Guideline. Rockville, Md: US Department of Health and Human Services, Public Health Service;2000.
6.
California plans asked to adopt smoking cessation benefit. Managed Care Outlook. 2004;17:9–11.
7.
McPhillips-TagnumCRehmBCarreonRAddressing tobacco in managed care: Results of the 2003 survey. Prev Chronic Dis. 2006;3:1–11.
8.
US Department of Health and Human Services. Healthy People 2010. 2nd ed.Washington, DC: US Government Printing Office;2000.
9.
FuhrmansV. Case grows to cover quitting. Wall Street Journal. April 26 2005;D1.
10.
McPhillips-TagnumCBocchinoCCarreonRAddressing tobacco in managed care: Results of the 2002 survey. Prev Chronic Dis. 2004;1:1–11.
11.
Centers for Disease Control and Prevention. State Medicaid coverage for tobacco-dependence treatments—United States, 2005. MMWR. 2006;55:1194–1197.
12.
BlostinAP. Preventive care provisions, other benefits: Are they described in plan documents?Monthly Labor Rev. October 2002;13–19.
13.
BurnsMEBosworthTWFioreMC. Insurance coverage of smoking cessation treatment for state employees. Am J Public Health. 2004;94:1338–1340.
14.
CurrySJGrothausLCMcAfeeTPabiniakC. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. 1998;339:673–679.
15.
SchaufflerHHMcMenaminSOlsonKVariations in treatment benefits influence smoking cessation: Results of a randomized controlled trial. Tob Control. 2001;10:175–180.
16.
MarchA. The quantum lens. In: The Business Case for Tobacco Cessation Programs: A Case Study of Group Health Cooperative in Seattle. New York, NY: The Commonwealth Fund;2003.
17.
SolbergLIDavidsonGAlesciNLPhysician smoking-cessation actions: Are they dependent on insurance coverage or on patients?Am J Prev Med. 2002;23:160–165.
18.
BoyleRGSolbergLIMagnamSTrends: Does insurance coverage for drug therapy affect smoking-cessation?Health Aff. 2002;21:162–168.
19.
WestRDiMarinoMEGitchellJMcNeillA. Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control. 2005;14:166–171.
20.
Task Force on Community Preventive Services. The Guide to Preventive Services: What Works to Promote Health?New York, NY: Oxford University Press;2005.
21.
RanneyLMelvinCLuxLSystematic review: Smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med. 2006;145:845–856.
22.
WuPWilsonKDimoulasPMillsEJ. Effectiveness of smoking cessation therapies: A systematic review and meta-analysis. BMC Public Health. 2006;6:300–315.
WarnerKESmithRJSmithDGFriesBE. Health and economic implications of a work-site smoking cessation program: A simulation analysis. J Occup Environ Med. 1996;36:981–992.
25.
JavitzHSSwanGEZbikowskiSMReturn on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: An employer's perspective. Value Health. 2004;7:535–543.
26.
LevyDE. Employer-sponsored insurance coverage of smoking cessation treatments. Am J Manag Care. 2006;12:553–562.
27.
National Business Group on HealthCenter for Health and Preventive Services. Reducing the burden of smoking on employee health and productivity. Issues Brief. 2003;1 (5).